A
ARIUS Research Inc. — Investor Relations & Filings
Filings indexed
25
across all filing types
Latest filing
2008-09-24
Regulatory Filings
Country
CA
Canada
Listing
TSX
ARI
About ARIUS Research Inc.
ARIUS Research Inc. is a medical biotechnology company specializing in the discovery and development of antibody therapeutics. The company focuses on creating individualized, targeted therapy for cancer using monoclonal antibodies. Its pipeline targets various oncology indications, including breast, prostate, lung, ovarian, colorectal, and pancreatic cancers, as well as leukemia and melanoma. ARIUS is dedicated to advancing the next generation of antibody treatments for cancer and other diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2008-09-24 | English | |
| Material change report - English.pdf | 2008-07-31 | English | |
| Other.pdf | 2007-02-28 | English | |
| Other securityholders documents - English.pdf | 2006-12-05 | English | |
| Material change report - English.pdf | 2006-11-27 | English | |
| Other.pdf | 2006-06-13 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2008
2 filings
| |||||
| 47150430 | Material change report - English.pdf | 2008-09-24 | English | ||
| 47150436 | Material change report - English.pdf | 2008-07-31 | English | ||
|
2007
1 filing
| |||||
| 47150486 | Other.pdf | 2007-02-28 | English | ||
|
2006
5 filings
| |||||
| 47150499 | Other securityholders documents - English.pdf | 2006-12-05 | English | ||
| 47150503 | Material change report - English.pdf | 2006-11-27 | English | ||
| 47150506 | Other.pdf | 2006-06-13 | English | ||
| 47150525 | Material change report - English.pdf | 2006-03-10 | English | ||
| 47150528 | Material change report - English.pdf | 2006-02-10 | English | ||
|
2005
4 filings
| |||||
| 47150532 | Other.pdf | 2005-12-20 | English | ||
| 47150576 | Material change report - English.pdf | 2005-12-15 | English | ||
| 47150580 | Other.pdf | 2005-04-29 | English | ||
| 47150606 | Other.pdf | 2005-04-12 | English | ||
|
2003
3 filings
| |||||
| 47150665 | Other material contract(s).pdf | 2003-11-25 | English | ||
| 47150971 | Decision Document (Final).PDF | 2003-11-17 | English | ||
| 47150975 | Underwriting or agency agreement.pdf | 2003-11-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CASSAVA SCIENCES INC
Clinical-stage biotech developing treatments for Central Ne…
|
SAVA | US | Professional, scientific and te… |
|
Celcuity Inc.
Clinical-stage biotech developing targeted therapies for mu…
|
CELC | US | Professional, scientific and te… |
|
Cell Bio Human Tech Co., Ltd
Develops and manufactures cellulose-based nonwoven fabrics …
|
318160 | KR | Professional, scientific and te… |
|
CEL SCI CORP
Clinical-stage biotech developing immunotherapies for cance…
|
CVM | US | Professional, scientific and te… |
|
Celyad Oncology SA
Biotechnology company developing innovative CAR-T cell ther…
|
CYAD | BE | Professional, scientific and te… |
|
Ceres Power Holdings PLC
A developer of solid oxide technology for clean power and g…
|
CWR | GB | Professional, scientific and te… |
|
Certara, Inc.
Accelerates drug development using biosimulation software, …
|
CERT | US | Professional, scientific and te… |
|
CervoMed Inc.
A clinical-stage biotech developing treatments for age-rela…
|
CRVO | US | Professional, scientific and te… |
|
Chabiotech Co.,Ltd.
Develops cell/gene therapies and provides CDMO and bio-bank…
|
085660 | KR | Professional, scientific and te… |
|
CHAMPIONS ONCOLOGY, INC.
A CRO providing end-to-end solutions to accelerate oncology…
|
CSBR | US | Professional, scientific and te… |
ARIUS Research Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44939/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44939 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44939 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44939 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44939}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ARIUS Research Inc. (id: 44939)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.